Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 25, 2022

BUY
$242.49 - $301.46 $90,206 - $112,143
372 Added 39.49%
1,314 $323,000
Q2 2022

Aug 04, 2022

BUY
$224.73 - $338.64 $6,741 - $10,159
30 Added 3.29%
942 $233,000
Q1 2022

Apr 19, 2022

SELL
$277.25 - $366.29 $478,810 - $632,582
-1,727 Reduced 65.44%
912 $302,000
Q4 2021

Feb 01, 2022

BUY
$300.63 - $371.35 $644,851 - $796,545
2,145 Added 434.21%
2,639 $948,000
Q3 2021

Oct 15, 2021

BUY
$310.19 - $376.2 $28,847 - $34,986
93 Added 23.19%
494 $161,000
Q2 2021

Aug 06, 2021

BUY
$262.71 - $351.17 $17,601 - $23,528
67 Added 20.06%
401 $125,000
Q1 2021

May 07, 2021

SELL
$285.92 - $355.13 $85,204 - $105,828
-298 Reduced 47.15%
334 $106,000
Q4 2020

Feb 16, 2021

BUY
$251.88 - $324.2 $14,105 - $18,155
56 Added 9.72%
632 $205,000
Q3 2020

Nov 09, 2020

BUY
$255.22 - $317.0 $9,187 - $11,412
36 Added 6.67%
576 $160,000
Q2 2020

Aug 05, 2020

SELL
$141.4 - $257.09 $1,414 - $2,570
-10 Reduced 1.82%
540 $130,000
Q1 2020

May 05, 2020

BUY
$130.51 - $196.01 $7,961 - $11,956
61 Added 12.47%
550 $80,000
Q4 2019

Feb 14, 2020

BUY
$159.31 - $223.54 $12,426 - $17,436
78 Added 18.98%
489 $83,000
Q3 2019

Nov 14, 2019

SELL
$175.89 - $279.23 $175 - $279
-1 Reduced 0.24%
411 $73,000
Q2 2019

Aug 07, 2019

BUY
$250.96 - $284.94 $15,559 - $17,666
62 Added 17.71%
412 $107,000
Q1 2019

May 14, 2019

BUY
$276.39 - $362.25 $81,535 - $106,863
295 Added 536.36%
350 $100,000
Q4 2018

Feb 14, 2019

BUY
$281.08 - $444.25 $10,681 - $16,881
38 Added 223.53%
55 $18,000
Q3 2018

Nov 14, 2018

BUY
$354.53 - $449.75 $4,963 - $6,296
14 Added 466.67%
17 $8,000
Q2 2018

Aug 14, 2018

BUY
$278.07 - $446.21 $834 - $1,338
3 New
3 $1,000
Q1 2018

May 15, 2018

SELL
$192.49 - $295.85 $962 - $1,479
-5 Closed
0 $0
Q4 2017

Feb 14, 2018

BUY
$168.78 - $199.74 $843 - $998
5
5 $1,000

Others Institutions Holding ABMD

About ABIOMED INC


  • Ticker ABMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 45,460,900
  • Description
  • Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...
More about ABMD
Track This Portfolio

Track Fifth Third Bancorp Portfolio

Follow Fifth Third Bancorp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fifth Third Bancorp, based on Form 13F filings with the SEC.

News

Stay updated on Fifth Third Bancorp with notifications on news.